Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of Stinging Potential of BAY 987516
NCT02872207Completed
- Sponsor
- Bayer
- Start
- Feb 2015
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of BAY 987516 in sunburn (2 arms), sponsored by Bayer. Primary endpoints: Subjective discomfort in the eye at 24 hours, Tearing/Lacrimation at 24 hours and 9 more. Started Feb 2015; status: completed.
02
Drugs
BAY 987516
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT02872207.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872207.